The former president of Neuralink, a company co-founded by Elon Musk, has stated that the development of brain-computer interfaces (BCIs) should not be viewed as an aspirational, long-shot endeavor. This assertion comes at a time when Neuralink is making significant strides towards human implantation of its BCI technology, having recently received FDA approval for human trials. The company's stated goals include restoring lost motor function and eventually enhancing human cognitive abilities.
The significance of this perspective lies in its potential to reshape public and scientific expectations surrounding BCIs. Characterizing the technology as achievable rather than purely speculative could accelerate research funding, attract talent, and influence regulatory pathways. Neuralink's work builds upon decades of BCI research, but its high-profile status and Musk's ambitious vision have placed it at the forefront of public consciousness regarding the future of human-technology integration.
“Former President of Elon Musk's Neuralink: Brain-Computer Interface Is Not a "Moonshot Project"”
36 Kr
The Musk Wire aggregates and deduplicates public feeds; it does not republish articles. Continue to news.google.com to read the reporting in full.